• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

竞争风险回归中的模型选择。

Model selection in competing risks regression.

机构信息

Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.

出版信息

Stat Med. 2013 Aug 15;32(18):3077-88. doi: 10.1002/sim.5762. Epub 2013 Feb 24.

DOI:10.1002/sim.5762
PMID:23436643
Abstract

In the analysis of time-to-event data, the problem of competing risks occurs when an individual may experience one, and only one, of m different types of events. The presence of competing risks complicates the analysis of time-to-event data, and standard survival analysis techniques such as Kaplan-Meier estimation, log-rank test and Cox modeling are not always appropriate and should be applied with caution. Fine and Gray developed a method for regression analysis that models the hazard that corresponds to the cumulative incidence function. This model is becoming widely used by clinical researchers and is now available in all the major software environments. Although model selection methods for Cox proportional hazards models have been developed, few methods exist for competing risks data. We have developed stepwise regression procedures, both forward and backward, based on AIC, BIC, and BICcr (a newly proposed criteria that is a modified BIC for competing risks data subject to right censoring) as selection criteria for the Fine and Gray model. We evaluated the performance of these model selection procedures in a large simulation study and found them to perform well. We also applied our procedures to assess the importance of bone mineral density in predicting the absolute risk of hip fracture in the Women's Health Initiative-Observational Study, where mortality was the competing risk. We have implemented our method as a freely available R package called crrstep.

摘要

在处理时变数据的分析中,如果一个个体可能经历 m 种不同类型的事件中的一种且仅有一种,就会出现竞争风险的问题。竞争风险的存在使处理时变数据的分析变得复杂,标准的生存分析技术,如 Kaplan-Meier 估计、对数秩检验和 Cox 建模并不总是适用,并且应该谨慎应用。Fine 和 Gray 开发了一种回归分析方法,该方法对对应于累积发生率函数的风险进行建模。该模型正被临床研究人员广泛使用,现在已经在所有主要的软件环境中都可用。虽然已经为 Cox 比例风险模型开发了模型选择方法,但针对竞争风险数据的方法却很少。我们基于 AIC、BIC 和 BICcr(一种新提出的适用于右删失的竞争风险数据的修正 BIC)标准,为 Fine 和 Gray 模型开发了向前和向后的逐步回归程序作为选择标准。我们在一项大型模拟研究中评估了这些模型选择程序的性能,发现它们表现良好。我们还应用我们的程序来评估骨密度在预测妇女健康倡议观察研究中髋部骨折绝对风险中的重要性,其中死亡率是竞争风险。我们已经将我们的方法实现为一个免费的 R 包,称为 crrstep。

相似文献

1
Model selection in competing risks regression.竞争风险回归中的模型选择。
Stat Med. 2013 Aug 15;32(18):3077-88. doi: 10.1002/sim.5762. Epub 2013 Feb 24.
2
Cause-specific cumulative incidence estimation and the fine and gray model under both left truncation and right censoring.左截断和右删失情况下特定病因累积发病率估计及精细灰色模型
Biometrics. 2011 Mar;67(1):39-49. doi: 10.1111/j.1541-0420.2010.01420.x.
3
Cumulative incidence in competing risks data and competing risks regression analysis.竞争风险数据中的累积发病率及竞争风险回归分析。
Clin Cancer Res. 2007 Jan 15;13(2 Pt 1):559-65. doi: 10.1158/1078-0432.CCR-06-1210.
4
Semiparametric competing risks regression under interval censoring using the R package intccr.使用 R 包 intccr 进行区间 censoring 下的半参数竞争风险回归。
Comput Methods Programs Biomed. 2019 May;173:167-176. doi: 10.1016/j.cmpb.2019.03.002. Epub 2019 Mar 8.
5
Competing time-to-event endpoints in cardiology trials: a simulation study to illustrate the importance of an adequate statistical analysis.心脏病学试验中相互竞争的事件发生时间终点:一项模拟研究以说明充分统计分析的重要性。
Eur J Prev Cardiol. 2014 Jan;21(1):74-80. doi: 10.1177/2047487312460518. Epub 2012 Sep 10.
6
Assessing risk factors of non-fatal outcomes amid a competing risk of mortality: the example of hip fracture.评估死亡竞争风险下的非致命结局的危险因素:以髋部骨折为例。
Osteoporos Int. 2019 Oct;30(10):2073-2078. doi: 10.1007/s00198-019-05048-w. Epub 2019 Jun 29.
7
Prognostic models with competing risks: methods and application to coronary risk prediction.具有竞争风险的预后模型:方法及其在冠心病风险预测中的应用
Epidemiology. 2009 Jul;20(4):555-61. doi: 10.1097/EDE.0b013e3181a39056.
8
Performing Survival Analyses in the Presence of Competing Risks: A Clinical Example in Older Breast Cancer Patients.存在竞争风险时进行生存分析:老年乳腺癌患者的临床实例。
J Natl Cancer Inst. 2015 Nov 26;108(5). doi: 10.1093/jnci/djv366. Print 2016 May.
9
Evaluating health outcomes in the presence of competing risks: a review of statistical methods and clinical applications.在存在竞争风险的情况下评估健康结局:统计方法和临床应用的综述。
Med Care. 2010 Jun;48(6 Suppl):S96-105. doi: 10.1097/MLR.0b013e3181d99107.
10
Tree-based models for survival data with competing risks.基于树的竞争风险生存数据分析模型。
Comput Methods Programs Biomed. 2018 Jun;159:185-198. doi: 10.1016/j.cmpb.2018.03.017. Epub 2018 Mar 21.

引用本文的文献

1
Impact of Limited Sample Size and Follow-up on Partitioned Survival and Multistate Modeling-Based Health Economic Models: A Simulation Study.有限样本量和随访对基于分区生存和多状态建模的健康经济模型的影响:一项模拟研究
Med Decis Making. 2025 Aug;45(6):714-725. doi: 10.1177/0272989X251342596. Epub 2025 Jun 25.
2
Integrated analysis of molecular and clinical features associated with overall survival in melanoma patients with brain metastasis.黑色素瘤脑转移患者总生存相关分子特征与临床特征的综合分析
Acta Neuropathol Commun. 2025 Apr 15;13(1):75. doi: 10.1186/s40478-025-01978-1.
3
A predictive model for therapy failure in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitor therapy.
慢性髓性白血病患者接受酪氨酸激酶抑制剂治疗后治疗失败的预测模型。
Blood. 2024 Oct 31;144(18):1951-1961. doi: 10.1182/blood.2024024761.
4
Informing Structural Assumptions for Three State Oncology Cost-Effectiveness Models through Model Efficiency and Fit.通过模型效率和拟合度为三个州立肿瘤学成本效益模型提供结构假设。
Appl Health Econ Health Policy. 2024 Sep;22(5):619-628. doi: 10.1007/s40258-024-00884-2. Epub 2024 May 21.
5
Prediction of cardiovascular risk in patients with hepatocellular carcinoma receiving anti-angiogenic drugs: lessons from sorafenib.接受抗血管生成药物治疗的肝细胞癌患者心血管风险预测:索拉非尼的经验教训。
Intern Emerg Med. 2024 Jun;19(4):1151-1160. doi: 10.1007/s11739-024-03578-8. Epub 2024 Mar 29.
6
Competing risks modeling of length of hospital stay enhances risk-stratification of patient care: application to under-five children hospitalized in Malawi.住院时间的竞争风险建模可增强患者护理的风险分层:应用于马拉维住院的五岁以下儿童。
Front Epidemiol. 2023 Nov 13;3:1274776. doi: 10.3389/fepid.2023.1274776. eCollection 2023.
7
Competing-risks analysis for evaluating the prognosis of patients with microinvasive cutaneous squamous cell carcinoma based on the SEER database.基于 SEER 数据库的竞争风险分析评估微小浸润性皮肤鳞状细胞癌患者的预后。
BMC Med Res Methodol. 2023 Dec 7;23(1):286. doi: 10.1186/s12874-023-02109-x.
8
High Risk of New HPV Infection Acquisition Among Unvaccinated Young Men.未接种 HPV 疫苗的年轻男性新感染 HPV 的风险高。
J Infect Dis. 2024 Mar 14;229(3):707-718. doi: 10.1093/infdis/jiad485.
9
Can spirometry improve the performance of cardiovascular risk model in high-risk Eastern European countries?在东欧高危国家,肺功能测定能否改善心血管风险模型的性能?
Front Cardiovasc Med. 2023 Aug 29;10:1228807. doi: 10.3389/fcvm.2023.1228807. eCollection 2023.
10
Pembrolizumab alone or in combination with chemotherapy versus chemotherapy for advanced gastric cancer: A cost-effectiveness analysis.帕博利珠单抗单药或联合化疗对比化疗治疗晚期胃癌的成本效益分析
Cancer Med. 2023 Sep;12(18):18447-18459. doi: 10.1002/cam4.6389. Epub 2023 Sep 14.